Navigation Links
Promising Therapy for Prostate Cancer
Date:6/22/2009

Experimental drug beat back inoperable cancer in two patients, study claims

MONDAY, June 22 (HealthDay News) -- An experimental drug therapy appears to have helped destroy allegedly inoperable prostate cancer in two patients in a clinical trial.

Use of the immunotherapeutic agent MDX-010, or ipilimumab, in combination with standard hormone and radiation treatments helped eliminate the aggressive tumors, which had already spread into the patients' abdominal areas, according to a report from Mayo Clinic researchers that appears in Discovery's Edge, the Mayo Clinic's online research magazine. Both patients are now considered cancer-free.

"The tumors had shrunk dramatically," co-investigator Dr. Michael Blute, a Mayo urologist and surgeon who operated on both patients, said in a Mayo Clinic news release. "I had never seen anything like this before. I had a hard time finding the cancer. At one point, the pathologist [who was working during surgery] asked if we were sending him samples from the same patient."

Ipilimumab is an antibody that appears to greatly magnify the cancer-killing action of androgen ablation, a hormone therapy that helps shrink prostate cancer by eliminating testosterone from the body. Following the additional treatment, the patients showed steady decreases in their prostate-specific antigen (PSA) counts, a test used to detect prostate cancer, and were deemed eligible for surgery. After surgery, one patient underwent additional radiation therapy.

"This is one of the Holy Grails of prostate cancer research," clinical trial leader Dr. Eugene Kwon, a Mayo Clinic urologist, said of the antibody therapy in the same news release.

The team plans more research into how ipilimumab works and how to optimize its use.

More information

The American Cancer Society has more about '/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

1

GOOD

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
3. Molecule Promising Against Huntingtons Disease
4. Computerized training of working memory is a promising therapeutic strategy in ADHD
5. Baicalin might be a promising therapeutic tool for severe acute pancreatitis
6. Initial Evaluation of New Nucleus Removal Device Provides Promising Results
7. Promising new TB drug given special status by US and European regulators
8. New Drug Promising Against Tough-to-Treat Kidney Cancer
9. Einstein scientists treat cancer as an infectious disease -- with promising results
10. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
11. Protalix BioTherapeutics prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promising Therapy for Prostate Cancer
Promising Therapy for Prostate Cancer
(Date:2/9/2010)... Alan Revell of Milford ... before he quit. What he witnessed was the inspiration for the ... "I just knew that there had to be a better way ... Rose Home Care. "What I saw in just one day was ... but I knew right then that we needed to find a ...
(Date:2/9/2010)... nutrition to cut obesity, ensure qualified recruits ,, ... General Johnnie E. Wilson , U.S. Army (Ret.), ... Force (Ret.), said Tuesday that preventing child obesity is ... has become the Number 1 reason why potential recruits ... generals, comments came in support of First Lady ...
(Date:2/9/2010)... MOUNTAIN VIEW, Calif. , Feb. 9 /PRNewswire/ ... of San Jose, California , has been re-elected ... Nurses, Association (ANNA) for 2010-11. ,, Doss, ... her position during ANNA,s 41st National Symposium ... 2010 . ,, As Western CCE, Doss will coordinate ...
(Date:2/9/2010)... training school, Pima Medical Institute, a leading private medical career ... program, the Bachelor of Science in Radiologic Sciences. This online ... school, and is also the first bachelor,s degree approved by ... Education Schools (ABHES). , ... Tucson, ...
(Date:2/9/2010)... features videos, chat, extensive smile gallery and other resources and ... ... York, NY (PRWEB) February 9, 2010 -- Leading specialists in ... City office announces the launch of its new Web site, ... and helpful information regarding the office’s services and cosmetic dental ...
Breaking Medicine News(10 mins):Health News:Caring Rose Home Care Launched To Help Seniors Live Independently 2Health News:Retired Military Brass Support First Lady's Call to Reduce Child Obesity, Improve Nutrition 2Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 2Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 3Health News:Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program 2Health News:Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program 3Health News:Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program 4Health News:Top New York Dentists at Smile in the City Launch New Web Site 2
... cracked the mystery of the deaths of thousands of ... ,Eye and throat disease had killed the young farmed ... farms in recent past weeks. ,Veterinary pathologist ... cold dry season and exposure of hatchlings to older ...
... Zealand are not getting enough sun, and as a ... making a comeback, experts have revealed in the latest ... nutritional rickets are again emerging as major paediatric health ... Munns, paediatric endocrinologist at the Children’s Hospital at Westmead, ...
... an outbreak of the deadly bird flu following reports of ... first of these cases was reported in the village of ... miles south of Cairo. ,Following this report all ... to check that none of the people who had been ...
... advice to women of childbearing age, who would indeed be ... of delivering a child with birth defects. // , ... with intake of vitamins and minerals, the risk of many ... be offset include neural-tube defects such as spina bifida, brain-damaging ...
... medical students are unprepared for skilled prescribing, warn doctors ... UK is abundant, write Jeffrey Aronson and colleagues.// Effective ... especially when new doctors start work in hospitals. ... say the authors. Some relate to system failures, while ...
... diabetes in pregnancy has increased four times among Australian women ... may cause problems for babies. In NSW the rate has ... Australia NSW president Neville Howard said it was a dangerous ... change so dramatic that record numbers of pregnant mothers in ...
Other Medicine News:Health News:More Sunshine for At-Risk Kids 2Health News:Many Medical Students Unprepared for Skilled Prescribing 2
(Date:2/9/2010)... 9 Palatin Technologies, Inc. (NYSE ... of first cohort dosing in a placebo-controlled, multiple ... sexual dysfunction.  The primary endpoint in this double-blind ... of subcutaneous bremelanotide in men between 45 and ... consistency of plasma exposure of bremelanotide given as ...
(Date:2/8/2010)... Cost reductions offset a recession-driven sales decline ... narrowly back into profitability in the second quarter of ... December 31, 2009 declined almost 9 percent, ... quarter last year to $11.4 million in ... reduced even more sharply, from approximately $9.8 million ...
(Date:2/8/2010)... Initiative Drives Awareness for Improving the Safety of ... PARK, N.J. , Feb. 8 /PRNewswire-USNewswire/ ... of a new initiative to promote safer medication ... based on the American Society for Parenteral and ... The "Be A.W.A.R.E." campaign is designed to increase ...
Breaking Medicine Technology:Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 2Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 3Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 4Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 5Genetic Variant Slows AIDS Progression 61923 1Genetic Variant Slows AIDS Progression 61923 2Isis Pharmaceuticals 28Nasdaq 3A ISIS 29 Letter to Shareholders 61919 1Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 1Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 2
... Primary Tumors From Metastases in the ... With Accuracy Near 90%, Identifying Whether a Brain Malignancy is a Primary Tumor or ... Primary From Metastatic Tumors is Critical for ... Optimal Treatment, REHOVOT, Israel and JERSEY CITY, New ...
... , - PREVENAR Vaccine to Help ... Death in Young Children, Wyeth applauds ... of,Bahrain, Republic of Ireland, Slovak Republic and ... infants and young children against,pneumococcal disease by ...
Other Medicine Technology:Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 2Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 3Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 4Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 2Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 3
... The proven design of the Custom ... osteoarthritis by applying three-point load across ... form the degenerative area. The Diagonal ... ability to adjust the load to ...
... of the TROM provides the same easy ... as the full foam TROM, but is ... of use and versatility of the Cool ... following major ligament surgery, meniscal repairs, patella ...
... Fource Point Technology was developed to further ... of Leverage brace design. The patented Fource Point ... and offer an increasing resistance in the last ... extension shock and increase posterior tibial loads. The ...
Provides support and immobilization of the knee...
Medicine Products: